Especialistas ponderam após processar a FDA por acesso aos dados do teste da Pfizer

Demasi, Maryanne

Found an issue? Give us feedback

ZENODOarrow_drop_down

ZENODO

Article . 2022

License: CC BY

Data sources: Datacite

ZENODO

Article . 2022

License: CC BY

Data sources: Datacite

ZENODO

Article . 2022

License: CC BY

Data sources: ZENODO

Especialistas ponderam após processar a FDA por acesso aos dados do teste da Pfizer

descriptionPublicationkeyboard_double_arrow_right Article 02 Jun 2022 Portuguese Publisher:Zenodo

Authors: Demasi, Maryanne;

doi: 10.5281/zenodo.6608384 , 10.5281/zenodo.6608385

Especialistas ponderam após processar a FDA por acesso aos dados do teste da Pfizer

- Summary
- Subjects
- Metrics

Abstract

Considerações éticas sobre o processo da FDA por acesso aos dados do teste da Pfizer

Keywords

AUE, EUA, transparência na pesquisa, dados de ensaios clínicos, FDA, ARNm, Comirnaty, Public Health and Medical Professionals for Transparency, PHMPT, Jefferson, Departamento de Justiça, Informação de eventos adversos, farmacovigilancia, Kheriaty, FOIA, Segredo comercial, vacinas, Covid-19, pandemia

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average